Literature DB >> 25398583

Implementation of cervical cancer screening and prevention in China--challenges and reality.

Shao-Ming Wang1, You-Lin Qiao2.   

Abstract

This article summarizes great efforts that Chinese scholars had made in fighting against cervical cancer from aspects of the epidemiology, etiology, population-based screening studies, novel screening technology development, guideline, strategy and policy making and population delivery. After decades of continuous efforts, Chinese scientists successfully translated their scientific discovery to appropriate screening product development and eventually, delivered it to the whole population. We hope our experience could serve as a 'case-story' for cancer prevention in other low- and middle-income countries. Moreover, challenges confronted in the prevention and control of cervical cancer in China are reviewed as well to appeal for future multi-collaborations and potential solutions to acquire the final success of the campaign.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  China; cervical cancer; prevention; public health; screening

Mesh:

Year:  2014        PMID: 25398583     DOI: 10.1093/jjco/hyu188

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  18 in total

1.  Modeling the epidemiological impact and cost-effectiveness of a combined schoolgirl HPV vaccination and cervical cancer screening program among Chinese women.

Authors:  Xiaomeng Ma; Katherine Harripersaud; Kumi Smith; Christopher K Fairley; Huachun Zou; Zhuoru Zou; Yueyun Wang; Guihua Zhuang; Lei Zhang
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

2.  MicroRNA-195 inhibits proliferation of cervical cancer cells by targeting cyclin D1a.

Authors:  Ning Wang; Heng Wei; Duo Yin; Yanming Lu; Yao Zhang; Qiao Zhang; Xiaoxin Ma; Shulan Zhang
Journal:  Tumour Biol       Date:  2015-10-28

3.  Regulator role of HPV E7 protein on miR-21 expression in cervical carcinoma cells and its functional implication.

Authors:  Qingqin Kong; Wenfeng Wang; Ping Li
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

4.  High methylation of ZNF582 in cervical adenocarcinoma affects radiosensitivity and prognosis.

Authors:  Na-Yi Yuan Wu; Xiaoyun Zhang; Tangyuan Chu; Songlin Zhu; Yuping Deng; Yi Zhou; Ying Wang; Xueheng Zhao; Lu Liu; Chao Fang; Yang Wang; Yu-Ligh Liou; Jingting Cai; Jing Wang
Journal:  Ann Transl Med       Date:  2019-07

5.  Impact of antiviral AV2 in the topical treatment of HPV-associated lesions of the cervix: Results of a phase III randomized placebo-controlled trial.

Authors:  Alex Baleka Mutombo; Rahma Tozin; Hollande Kanyiki; Jean-Pierre Van Geertruyden; Yves Jacquemyn
Journal:  Contemp Clin Trials Commun       Date:  2019-05-16

6.  The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.

Authors:  Miao-Fang Wu; Mei-Mei Guan; Chang-Hao Liu; Jie-Ying Wu; Qun-Xian Rao; Jing Li
Journal:  Cancer Med       Date:  2019-07-16       Impact factor: 4.452

7.  Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review.

Authors:  Dongyu Zhang; Shailesh Advani; Jo Waller; Ana-Paula Cupertino; Alejandra Hurtado-de-Mendoza; Anthony Chicaiza; Peter J Rohloff; Tomi F Akinyemiju; Eduardo Gharzouzi; Megan J Huchko; Joaquin Barnoya; Dejana Braithwaite
Journal:  JCO Glob Oncol       Date:  2020-04

8.  Status of Human Papillomavirus Infection in the Ethnic Population in Yunnan Province, China.

Authors:  Zulqarnain Baloch; Lei Yue; Tao Yuan; Yue Feng; Wenlin Tai; Yanqing Liu; Binghui Wang; Xiao Li; Li Liu; A-Mei Zhang; Xiaomei Wu; Xueshan Xia
Journal:  Biomed Res Int       Date:  2015-12-27       Impact factor: 3.411

9.  Knowledge and Awareness of Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccine Among HPV-Infected Chinese Women.

Authors:  Zulqarnain Baloch; Nafeesa Yasmeen; Yuanyue Li; Wenhui Zhang; Hongyu Lu; Xiaomei Wu; Xueshan Xia; Shihua Yang
Journal:  Med Sci Monit       Date:  2017-09-04

10.  Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.

Authors:  Dongman Zhao; Liran Zhang; Fengxiang Xie; Dezhi Peng; Jie Wei; Lingbo Jiang; Shoudu Zhang; Debo Qi
Journal:  BMC Cancer       Date:  2020-08-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.